Lunai Bioworks Inc. (LNAI) Balance Sheet

NASDAQ: LNAIAssets, liabilities, debt and equity over 6 years.

LNAI balance sheet, FY2026

June 30, 2026 · U.S. dollars

$9.94B assets = $18.97B liabilities + −$9.02B equity

What it owns$9.94BCash & ST investments: $1.71B (17.2%)$1.71BOther current: $322.7M (3.2%)PP&E: $12.0M (0.1%)Goodwill & intangibles: $7.78B (78.3%)Goodwill & intangibles$7.78B · 78%Other non-current: $111.0M (1.1%)=How it is financed$18.97BCurrent liabilities: $18.91B (99.7%)Current liabilities$18.91B · 100%Other LT liabilities: $56.2M (0.3%)

Liabilities exceed assets: shareholders’ equity is negative (−$9.02B).

Both columns are drawn to the same scale: what LNAI owns equals what it owes plus shareholders’ equity. Hover a block for its value.

LNAI financial health

Current ratio0.11
Tight · current assets cover current liabilities 0.11×
Equity / assets−90.8%
Thin equity · of assets funded by shareholders
Cash / debt128.0%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles78.3%
Mostly intangible · of total assets

Descriptive bands, not a rating. Fiscal FY2026.

LNAI balance sheet trends, FY2021–FY2026

Lunai Bioworks Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$189.6MFY2021$9.94BFY2026+120.8%/yr
Total liabilities$14.9MFY2021$18.97BFY2026+317.6%/yr
Shareholders’ equity$174.7MFY2021−$9.02BFY2026—
Cash & short-term investments$20.7MFY2021$1.71BFY2026+142.0%/yr
Total debt$7.4MFY2021$1.34BFY2026+183.0%/yr
Net cash (debt)$13.3MFY2021$375.3MFY2026+$362.0M
Working capital$19.0MFY2021−$16.87BFY2026−$16.9B
Book value per share$108.27FY2024−$2,685.27FY2026—
Current ratio11.08FY20210.11FY2026−10.97
Debt / equity0.04FY20210.03FY2024−0.01
Shares outstanding1.2MFY20243.4MFY2026+66.0%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

LNAI assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

LNAI liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

LNAI debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

LNAI balance sheet

Lunai Bioworks Inc. annual balance sheet
FY2026FY2025FY2024FY2023FY2022FY2021
Assets
Cash & short-term investments$1.71B$480,551$220,467$1.9M$9.2M$20.7M
Cash & equivalents$1.71B$92,700$220,467$1.9M$9.2M$20.7M
Short-term investments—$387,851$0———
Receivables$0$0$1.1M$0$0$1,640
Inventory$0$0$0$0$0$0
Other current assets$322.7M$566,081$668,929$690,925$392,996$232,943
Total current assets$2.04B$1.0M$2.0M$2.6M$9.6M$20.9M
Property, plant & equipment (net)$12.0M$1.1M$1.8M$1.4M$1.7M$2.2M
Goodwill & intangible assets$7.78B$6.1M$159.4M$54.3M$73.3M$166.5M
Long-term investments$0$0$0$0$0$0
Other non-current assets$111.0M$0$19,849$21,741$68,635$20,984
Total assets$9.94B$8.2M$163.1M$58.3M$84.6M$189.6M
Liabilities
Accounts payable$12.4M$12.6M$9.4M$5.3M$1.4M$320,559
Short-term debt$1.28B$9.7M$2.9M$4.8M$1.5M$353,007
Total current liabilities$18.91B$29.2M$30.3M$11.0M$6.5M$1.9M
Long-term debt$0$0$0$0$4.6M$0
Lease obligations—$737,594$1.3M$969,009$1.2M—
Other long-term liabilities$56.2M$424,547$842,389$775,587$985,699$13.1M
Total liabilities$18.97B$29.6M$31.2M$11.8M$12.0M$14.9M
Shareholders' equity
Common stock & paid-in capital$462$17,741$15,847$6,371$5,302$5,222
Retained earnings (deficit)−$514.0M−$510.5M−$332.5M−$244.0M−$204.3M−$90.9M
Accumulated other comprehensive income−$156,057$10.8M−$170,846−$29,882−$30,436−$10,834
Total shareholders' equity−$9.02B−$21.3M$132.0M$46.5M$72.6M$174.7M
Key figures
Total debt$1.34B$10.2M$3.8M$5.6M$7.0M$7.4M
Net cash (debt)$375.3M−$9.7M−$3.6M−$3.7M$2.2M$13.3M
Working capital−$16.87B−$28.1M−$28.3M−$8.5M$3.1M$19.0M
Tangible book value−$16.81B−$27.5M−$27.4M−$7.8M−$636,420$8.1M
Book value per share−$2,685.27−$10.35$108.27———
Shares outstanding3.4M2.1M1.2M———
Current ratio0.110.040.070.231.4811.08
Quick ratio0.090.020.040.171.4210.96
Debt / equity——0.030.120.100.04
Equity / assets−90.8%−259.4%80.9%79.8%85.8%92.1%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed October 13, 2026); data from EODHD.

LNAI financial position

At the end of fiscal 2026 (June 30, 2026), Lunai Bioworks had total assets of $9.9 billion (up 120,687.0% from a year earlier), total liabilities of $19.0 billion and shareholders' equity of -$9.0 billion. It held $1.7 billion in cash and short-term investments against $1.3 billion of debt, a net cash position of $375.3 million. Its current ratio was 0.11. In the latest quarter (ended September 30, 2026) total assets were $9.9 billion and equity -$9.0 million.

Related: LNAI income statement, LNAI cash flow statement, LNAI key metrics. See the LNAI stock overview for the latest quote and news.

LNAI balance sheet FAQ

What are Lunai Bioworks's total assets?

Lunai Bioworks reported total assets of $9.9 billion at the end of fiscal 2026 (June 30, 2026), compared with $8.2 million a year earlier.

How much debt does Lunai Bioworks have?

Lunai Bioworks had $1.3 billion of total debt at the end of fiscal 2026, including short-term borrowings. Its debt-to-equity ratio was —.

How much cash does Lunai Bioworks have?

Lunai Bioworks held $1.7 billion in cash and short-term investments at the end of fiscal 2026; with $1.3 billion of debt that is net cash of $375.3 million.

What is Lunai Bioworks's book value?

Lunai Bioworks's shareholders' equity (book value) was -$9.0 billion at the end of fiscal 2026, or −$2,685.27 per share.

What is Lunai Bioworks's current ratio?

Lunai Bioworks had current assets of $2.0 billion and current liabilities of $18.9 billion, a current ratio of 0.11 (current liabilities exceed current assets).

How much goodwill does Lunai Bioworks have?

Lunai Bioworks carried $7.8 billion of goodwill and intangible assets, 78.3% of total assets, at the end of fiscal 2026.

Biotechnology: balance sheet